Wedmont Private Capital Astrazeneca PLC Transaction History
Wedmont Private Capital
- $2.73 Billion
- Q4 2025
A detailed history of Wedmont Private Capital transactions in Astrazeneca PLC stock. As of the latest transaction made, Wedmont Private Capital holds 11,901 shares of AZN stock, worth $1.06 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,901
Previous 10,855
9.64%
Holding current value
$1.06 Million
Previous $832,000
27.76%
% of portfolio
0.04%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,545Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...